May 2018 $30 M No. 5 $10 to $50 million 30
Silk Therapeutics, Inc.: Raise no. 5, May 2018 × Investors in this round 30 investors had bought by the notice of Jan 3, 2019: 30 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $30 M of $30 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Gregory Altman · Executive Officer, Director Rebecca Lacouture · Executive Officer, Director Scott Packard · Executive Officer Brendan O'Leary · Director Daniel Kraft · Director Jeffrey Vinik · Director Robert Pangia · Director Roy Disney · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Scott Packard, Chief Financial Officer. Source: SEC Form D, newest notice filed Jan 3, 2019. Read the notice at the SEC .
equity SEC Jul 2017 $10 M No. 4 $10 to $50 million 24
Silk Therapeutics, Inc.: Raise no. 4, Jul 2017 × Investors in this round 24 investors had bought by the notice of Aug 2, 2017: 24 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $10 M of $15 M offered; $5 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Gregory Altman · Executive Officer, Director, Promoter Rebecca Horan · Executive Officer, Director Scott Packard · Executive Officer Brendan O'Leary · Director Daniel Kraft · Director Roy Disney · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Scott Packard, Chief Financial Officer. Source: SEC Form D, newest notice filed Aug 2, 2017. Read the notice at the SEC .
equity SEC Jan 2016 $6 M No. 3 $2 to $10 million 19
Silk Therapeutics, Inc.: Raise no. 3, Jan 2016 × Investors in this round 19 investors had bought by the notice of Feb 4, 2016: 19 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $6 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Gregory Altman · Executive Officer, Director, Promoter Rebecca Horan · Executive Officer, Director Brendan O'Leary · Director Daniel Kraft · Director Sheri Disney · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Gregory Altman, President. Source: SEC Form D, newest notice filed Feb 4, 2016. Read the notice at the SEC .
equity SEC Aug 2014 $1 M No. 2 Under $2 million 9
Silk Therapeutics, Inc.: Raise no. 2, Aug 2014 × Investors in this round 9 investors had bought by the notice of Oct 7, 2014: 9 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $2 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Gregory Altman · Executive Officer, Director, Promoter Rebecca Horan · Executive Officer, Director Brendan O'Leary · Director Daniel Kraft · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Gregory Altman, President. Source: SEC Form D, newest notice filed Oct 7, 2014. Read the notice at the SEC .
equity SEC Feb 2014 $1 M No. 1 Under $2 million 11
Silk Therapeutics, Inc.: Raise no. 1, Feb 2014 × Investors in this round 11 investors had bought by the notice of Mar 24, 2014: 11 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $2 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Gregory Altman · Executive Officer, Director, Promoter Rebecca Horan · Executive Officer, Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Gregory Altman, President. Source: SEC Form D, newest notice filed Mar 24, 2014. Read the notice at the SEC .
equity SEC